Otsuka (OTCMKTS:OTSKY) Shares Gap Down – Should You Sell?

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s share price gapped down prior to trading on Monday . The stock had previously closed at $34.27, but opened at $33.01. Otsuka shares last traded at $34.55, with a volume of 2,499 shares trading hands.

Analyst Ratings Changes

Several brokerages have commented on OTSKY. Morgan Stanley raised shares of Otsuka to an “overweight” rating in a research report on Friday, January 23rd. UBS Group raised Otsuka to a “hold” rating in a research report on Tuesday, January 27th. Zacks Research lowered Otsuka from a “hold” rating to a “strong sell” rating in a report on Monday, March 2nd. Finally, The Goldman Sachs Group cut Otsuka from a “strong-buy” rating to a “strong sell” rating in a research report on Friday, February 27th. One investment analyst has rated the stock with a Buy rating, one has issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce”.

Otsuka Trading Up 0.7%

The company has a market cap of $37.56 billion and a P/E ratio of 15.20. The business’s 50-day moving average price is $31.47 and its 200 day moving average price is $29.16. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.